New Delhi, Jan 2: The Central Government on Saturday said that the expert panel of India’s drug regulator has recommended granting permission for restricted emergency use of the indigenously developed Covid-19 vaccine ‘Covaxin’ in ‘public interest as an abundant precaution.’
The Subject Expert Committee of Central Drugs Standards Control Organisation had met on January 1 and 2, and made the following recommendations for the consideration and final decision of the Drugs Controller General of India. The final decision will be taken by DCGI VG Somani soon.
‘Grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains, to Bharat Biotech International,’ the centre said in a statement. (Contd on P-4)
